This compound is a deuterated derivative of phenylacetonitrile, where all hydrogen atoms on the phenyl ring and the benzylic methylene group are replaced by deuterium. It is primarily used as an intermediate in the synthesis of deuterated pharmaceuticals, leveraging the kinetic isotope effect to improve metabolic stability.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 65538-26-3
(²H₅)Phenyl(²H₂)methanol
pharmaceutical intermediate
(+/-)-Felodipine (2,3-dichlorophenyl-d3)
pharmaceutical intermediate
1-carbamate-3-(2-methoxy-D3-phenoxy)-1,2-propanediol
pharmaceutical intermediate
N,N-Bis[(²H₃)methyl](²H₃)acetamide
pharmaceutical intermediate
2-Bromo-3-methyl-5-chloropyridine
pharmaceutical intermediate
2-Bromo-3-chloro-5-methylpyridine
pharmaceutical intermediate
3-[(Benzyloxycarbonyl)amino]propionaldehyde
pharmaceutical intermediate
1-Pyrrolidineethanamine dihydrochloride
pharmaceutical intermediate
2,2-dideuterio-2-(2,3,4,5,6-pentadeuteriophenyl)acetonitrile
SUSQOBVLVYHIEX-XZJKGWKKSA-N
[2H]C1=C(C(=C(C(=C1[2H])[2H])C([2H])([2H])C#N)[2H])[2H]
—